Formerly known as Pathologics, LLC, Adarza BioSystems, Inc is an early stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. With the underpinning technology licensed from University of Rochester Medical Center, while still maintaing a NY state presence, headquartrers of the firm is now moved to St Louis, MO. In addition to performing sophisticated clinical tests within minutes, the firm's technology is fully arrayable, potentially allowing hundreds of tests to be run simultaneously on a single chip. Sample antibody array AIR image taken on the Adarza BioSystems, Inc prototype optical reader. Spot size is ~100Âµm This proprietary platform technology will enable not only the next generation of clinical devices, but will revolutionize the medical diagnostics field. Ultimately, we envision this technology driving a broad range of devices from future in-home diagnostics where the patient will self-diagnose illness with minimal physician input, to large-scale customizable research grade instrumentation. Adarza's proprietary chip-based platform, Arrayed Imaging Reflectometry (AIR), achieves high sensitivity by detecting intensity changes in images of antireflective chips functionalized with highly specific detection molecules (proteins, DNA, etc.).